These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 16226997
1. Structural changes of smooth muscle in congenital ureteropelvic junction obstruction. Hosgor M, Karaca I, Ulukus C, Ozer E, Ozkara E, Sam B, Ucan B, Kurtulus S, Karkiner A, Temir G. J Pediatr Surg; 2005 Oct; 40(10):1632-6. PubMed ID: 16226997 [Abstract] [Full Text] [Related]
2. Smooth muscle cell apoptosis and defective neural development in congenital ureteropelvic junction obstruction. Kajbafzadeh AM, Payabvash S, Salmasi AH, Monajemzadeh M, Tavangar SM. J Urol; 2006 Aug; 176(2):718-23; discussion 723. PubMed ID: 16813927 [Abstract] [Full Text] [Related]
3. Renal pelvis cuff pyeloplasty for ureteropelvic junction obstruction for the high inserting ureter: an initial experience. Palmer LS, Proano JM, Palmer JS. J Urol; 2005 Sep; 174(3):1088-90. PubMed ID: 16094065 [Abstract] [Full Text] [Related]
4. Structural changes of collagen components and diminution of nerves in congenital ureteropelvic junction obstruction. Murakumo M, Nonomura K, Yamashita T, Ushiki T, Abe K, Koyanagi T. J Urol; 1997 May; 157(5):1963-8. PubMed ID: 9112572 [Abstract] [Full Text] [Related]
5. Extracellular matrix degradation and reduced neural density in children with intrinsic ureteropelvic junction obstruction. Kaya C, Bogaert G, de Ridder D, Schwentner C, Fritsch H, Oswald J, Radmayr C. Urology; 2010 Jul; 76(1):185-9. PubMed ID: 20303154 [Abstract] [Full Text] [Related]
6. Pathologic findings in patients with ureteropelvic junction obstruction and crossing vessels. Richstone L, Seideman CA, Reggio E, Bluebond-Langner R, Pinto PA, Trock B, Kavoussi LR. Urology; 2009 Apr; 73(4):716-9; discussion 719. PubMed ID: 19193425 [Abstract] [Full Text] [Related]
7. Collagen-to-smooth muscle ratio helps prediction of prognosis after pyeloplasty. Kim WJ, Yun SJ, Lee TS, Kim CW, Lee HM, Choi H. J Urol; 2000 Apr; 163(4):1271-5. PubMed ID: 10737527 [Abstract] [Full Text] [Related]
8. The roles of extracellular matrix proteins, apoptosis and c-kit positive cells in the pathogenesis of ureteropelvic junction obstruction. Özel SK, Emir H, Dervişoğlu S, Akpolat N, Şenel B, Kazez A, Söylet Y, Çetin G, Danişmend N, Büyükünal SN. J Pediatr Urol; 2010 Apr; 6(2):125-9. PubMed ID: 19716769 [Abstract] [Full Text] [Related]
9. Altered expression of interstitial cells of Cajal in congenital ureteropelvic junction obstruction. Solari V, Piotrowska AP, Puri P. J Urol; 2003 Dec; 170(6 Pt 1):2420-2. PubMed ID: 14634443 [Abstract] [Full Text] [Related]
18. The kidney in congenital ureteropelvic junction obstruction: a spectrum from normal to nephrectomy. Rosen S, Peters CA, Chevalier RL, Huang WY. J Urol; 2008 Apr; 179(4):1257-63. PubMed ID: 18280506 [Abstract] [Full Text] [Related]
19. Telocyte and Cajal cell distribution in renal pelvis, ureteropelvic junction (UPJ), and proximal ureter in normal upper urinary tract and UPJ obstruction: reappraisal of the aetiology of UPJ obstruction. Wishahi M, Mehena AA, Elganzoury H, Badawy MH, Hafiz E, El-Leithy T. Folia Morphol (Warsz); 2021 Apr; 80(4):850-856. PubMed ID: 33084013 [Abstract] [Full Text] [Related]
20. Elastin content of the renal pelvis and ureter determines post-pyeloplasty recovery. Kim DS, Noh JY, Jeong HJ, Kim MJ, Jeon HJ, Han SW. J Urol; 2005 Mar; 173(3):962-6. PubMed ID: 15711350 [Abstract] [Full Text] [Related] Page: [Next] [New Search]